Serial 98388773
Live / Applied — Third extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 02 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98388773
- Mark type
- Design / logo
- Filed
- 02 Feb 2024
- Published for opposition
- 19 Nov 2024
- Attorney of record
- Christie Baty Hudgins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy; pharmaceutical preparations that use genome editing to treat genetic, oncological, and immune system disorders and diseases
Owner
- Stylus Medicine, Inc., Cambridge, MA, US
- Stylus Medicine, Inc., Cambridge, MA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 3 GRANTED
- 31 Mar 2026 — SOU EXTENSION 3 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 2 GRANTED
- 17 Dec 2025 — SOU EXTENSION 2 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2025 — SOU EXTENSION 1 GRANTED
- 20 Jun 2025 — SOU EXTENSION 1 FILED
- 20 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION